ImageneBio (IMA) Invested Capital (2020 - 2024)
Historic Invested Capital for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $134.2 million.
- ImageneBio's Invested Capital fell 1359.05% to $134.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $134.2 million, marking a year-over-year decrease of 1359.05%. This contributed to the annual value of $169.8 million for FY2023, which is 1550.53% up from last year.
- According to the latest figures from Q3 2024, ImageneBio's Invested Capital is $134.2 million, which was down 1359.05% from $142.9 million recorded in Q2 2024.
- ImageneBio's 5-year Invested Capital high stood at $227.6 million for Q1 2021, and its period low was -$101.0 million during Q4 2020.
- Its 5-year average for Invested Capital is $118.8 million, with a median of $155.3 million in 2024.
- Per our database at Business Quant, ImageneBio's Invested Capital soared by 43471.15% in 2021 and then crashed by 3002.41% in 2023.
- Quarter analysis of 5 years shows ImageneBio's Invested Capital stood at -$101.0 million in 2020, then skyrocketed by 305.72% to $207.9 million in 2021, then decreased by 29.3% to $147.0 million in 2022, then increased by 15.51% to $169.8 million in 2023, then decreased by 20.93% to $134.2 million in 2024.
- Its Invested Capital was $134.2 million in Q3 2024, compared to $142.9 million in Q2 2024 and $155.3 million in Q1 2024.